• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

氧化应激作为前列腺癌进展的催化剂:揭示分子机制与探索治疗干预措施

Oxidative stress as a catalyst in prostate cancer progression: unraveling molecular mechanisms and exploring therapeutic interventions.

作者信息

Song Yawen, Hou Zheng, Zhu Longting, Chen Yan, Li Jingyu

机构信息

Department of Urology, Xijing Hospital of Air Force Military Medical University, Xi'an, China.

Department of Urology, Dandong Central Hospital, 70 Renmin Road, Zhenxing District, Dandong, 118000, Liaoning, China.

出版信息

Discov Oncol. 2025 Apr 3;16(1):457. doi: 10.1007/s12672-025-02245-4.

DOI:10.1007/s12672-025-02245-4
PMID:40178629
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11968600/
Abstract

Prostate cancer is the second most common malignancy among men worldwide, with its incidence and mortality rates steadily increasing. Although androgen deprivation therapy (ADT) combined with androgen receptor inhibitors has shown significant efficacy in treating prostate cancer, resistance to treatment remains a major challenge, particularly in patients with metastatic prostate cancer. Reactive oxygen species (ROS), a class of highly reactive molecules, can induce oxidative stress within cells, thereby affecting cellular survival and function. In cancer cells, elevated ROS levels not only promote proliferation and invasion but also contribute to the malignancy of tumors by modulating the tumor microenvironment, enhancing angiogenesis, and facilitating extracellular matrix remodeling. This review systematically explores the pathways of ROS generation in prostate cancer, their interaction with the androgen receptor signaling pathway, and the role of external factors such as obesity and aging in promoting ROS production. The findings highlight that ROS drive prostate cancer progression through multiple mechanisms, including altering the tumor microenvironment, activating the unfolded protein response (UPR), and regulating miRNA expression. By providing a comprehensive analysis of ROS-mediated mechanisms in prostate cancer, this review offers new insights into the development of targeted antioxidant therapeutic strategies.

摘要

前列腺癌是全球男性中第二常见的恶性肿瘤,其发病率和死亡率呈稳步上升趋势。尽管雄激素剥夺疗法(ADT)联合雄激素受体抑制剂在治疗前列腺癌方面已显示出显著疗效,但治疗耐药性仍然是一个主要挑战,尤其是在转移性前列腺癌患者中。活性氧(ROS)是一类高反应性分子,可诱导细胞内的氧化应激,从而影响细胞存活和功能。在癌细胞中,升高的ROS水平不仅促进增殖和侵袭,还通过调节肿瘤微环境、增强血管生成和促进细胞外基质重塑来促进肿瘤的恶性发展。本综述系统地探讨了前列腺癌中ROS产生的途径、它们与雄激素受体信号通路的相互作用,以及肥胖和衰老等外部因素在促进ROS产生中的作用。研究结果强调,ROS通过多种机制驱动前列腺癌进展,包括改变肿瘤微环境、激活未折叠蛋白反应(UPR)和调节miRNA表达。通过对前列腺癌中ROS介导机制的全面分析,本综述为靶向抗氧化治疗策略的开发提供了新的见解。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/12d0/11968600/5ad8e00dd6d6/12672_2025_2245_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/12d0/11968600/89f0fecf102c/12672_2025_2245_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/12d0/11968600/5ad8e00dd6d6/12672_2025_2245_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/12d0/11968600/89f0fecf102c/12672_2025_2245_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/12d0/11968600/5ad8e00dd6d6/12672_2025_2245_Fig2_HTML.jpg

相似文献

1
Oxidative stress as a catalyst in prostate cancer progression: unraveling molecular mechanisms and exploring therapeutic interventions.氧化应激作为前列腺癌进展的催化剂:揭示分子机制与探索治疗干预措施
Discov Oncol. 2025 Apr 3;16(1):457. doi: 10.1007/s12672-025-02245-4.
2
Androgen receptor contributes to repairing DNA damage induced by inflammation and oxidative stress in prostate cancer.雄激素受体有助于修复前列腺癌中由炎症和氧化应激诱导的DNA损伤。
Turk J Biol. 2023 Oct 11;47(5):325-335. doi: 10.55730/1300-0152.2667. eCollection 2023.
3
Interplay of oxidative stress, cellular communication and signaling pathways in cancer.氧化应激、细胞通讯和信号通路在癌症中的相互作用。
Cell Commun Signal. 2024 Jan 2;22(1):7. doi: 10.1186/s12964-023-01398-5.
4
Role of Natural and Synthetic Compounds in Modulating NRF2/KEAP1 Signaling Pathway in Prostate Cancer.天然和合成化合物在调节前列腺癌中NRF2/KEAP1信号通路中的作用
Cancers (Basel). 2023 Jun 2;15(11):3037. doi: 10.3390/cancers15113037.
5
Gene polymorphisms in antioxidant enzymes correlate with the efficacy of androgen-deprivation therapy for prostate cancer with implications of oxidative stress.抗氧化酶基因多态性与前列腺癌去势治疗疗效相关,并与氧化应激有关。
Ann Oncol. 2017 Mar 1;28(3):569-575. doi: 10.1093/annonc/mdw646.
6
Oxidative stress in prostate cancer.前列腺癌中的氧化应激
Cancer Lett. 2009 Sep 18;282(2):125-36. doi: 10.1016/j.canlet.2008.12.011. Epub 2009 Jan 30.
7
Oxidative stress and redox signaling in CRPC progression: therapeutic potential of clinically-tested Nrf2-activators.去势抵抗性前列腺癌进展中的氧化应激与氧化还原信号传导:经临床测试的Nrf2激活剂的治疗潜力
Cancer Drug Resist. 2021 Mar 19;4(1):96-124. doi: 10.20517/cdr.2020.71. eCollection 2021.
8
Androgen receptor as a driver of therapeutic resistance in advanced prostate cancer.雄激素受体作为晚期前列腺癌治疗耐药的驱动因素。
Int J Biol Sci. 2014 Jun 1;10(6):588-95. doi: 10.7150/ijbs.8671. eCollection 2014.
9
Relationship between purinergic signalling and oxidative stress in prostate cancer: Perspectives for future therapy.前列腺癌中嘌呤能信号传导与氧化应激之间的关系:未来治疗的展望
Crit Rev Oncol Hematol. 2025 May;209:104675. doi: 10.1016/j.critrevonc.2025.104675. Epub 2025 Feb 25.
10
Androgen receptor dynamics in prostate cancer: from disease progression to treatment resistance.前列腺癌中的雄激素受体动态变化:从疾病进展到治疗抵抗
Front Oncol. 2025 Feb 11;15:1542811. doi: 10.3389/fonc.2025.1542811. eCollection 2025.

引用本文的文献

1
The Potential Mechanisms of Ochratoxin A in Prostate Cancer Development: An Integrated Study Combining Network Toxicology, Machine Learning, and Molecular Docking.赭曲霉毒素A在前列腺癌发生发展中的潜在机制:一项结合网络毒理学、机器学习和分子对接的综合研究
Toxins (Basel). 2025 Aug 4;17(8):388. doi: 10.3390/toxins17080388.
2
Biochemical and Histological Characterization of Sorcin Overexpression in Patients Who Underwent Radical Prostatectomy.接受根治性前列腺切除术患者中索拉菌素过表达的生化和组织学特征
Urol Res Pract. 2025 Jun 24;51(3):105-110. doi: 10.5152/tud.2025.24188.

本文引用的文献

1
Shedding light on the shadows: oxidative stress and its pivotal role in prostate cancer progression.揭示阴影:氧化应激及其在前列腺癌进展中的关键作用。
Front Oncol. 2024 May 7;14:1393078. doi: 10.3389/fonc.2024.1393078. eCollection 2024.
2
Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.2022 年全球癌症统计数据:全球 185 个国家和地区 36 种癌症的发病率和死亡率全球估计数。
CA Cancer J Clin. 2024 May-Jun;74(3):229-263. doi: 10.3322/caac.21834. Epub 2024 Apr 4.
3
The role of oxidative stress and inflammation biomarkers in pre- and postoperative monitoring of prostate cancer patients.
氧化应激和炎症生物标志物在前列腺癌患者术前和术后监测中的作用。
Free Radic Res. 2024 Feb;58(2):98-106. doi: 10.1080/10715762.2024.2320381. Epub 2024 Feb 23.
4
Identification of Molecular Markers Associated with Prostate Cancer Subtypes: An Integrative Bioinformatics Approach.鉴定与前列腺癌亚型相关的分子标志物:一种综合生物信息学方法。
Biomolecules. 2024 Jan 10;14(1):87. doi: 10.3390/biom14010087.
5
Decoding the Influence of Obesity on Prostate Cancer and Its Transgenerational Impact.解析肥胖对前列腺癌的影响及其跨代效应。
Nutrients. 2023 Nov 21;15(23):4858. doi: 10.3390/nu15234858.
6
Overexpression of Glutathione S-Transferases in Human Diseases: Drug Targets and Therapeutic Implications.谷胱甘肽S-转移酶在人类疾病中的过表达:药物靶点与治疗意义
Antioxidants (Basel). 2023 Nov 6;12(11):1970. doi: 10.3390/antiox12111970.
7
Oxidant-modified amylin fibrils and aggregates alter the inflammatory profile of multiple myeloid cell types, but are non-toxic to islet β cells.氧化修饰的淀粉样肽纤维和聚集体改变了多种骨髓细胞类型的炎症特征,但对胰岛β细胞没有毒性。
Redox Biol. 2023 Sep;65:102835. doi: 10.1016/j.redox.2023.102835. Epub 2023 Jul 31.
8
"Double-edged sword" effect of reactive oxygen species (ROS) in tumor development and carcinogenesis.活性氧(ROS)在肿瘤发生和致癌作用中的“双刃剑”效应。
Physiol Res. 2023 Jul 14;72(3):301-307. doi: 10.33549/physiolres.935007.
9
Antiandrogen treatment induces stromal cell reprogramming to promote castration resistance in prostate cancer.抗雄激素治疗诱导基质细胞重编程以促进前列腺癌去势抵抗。
Cancer Cell. 2023 Jul 10;41(7):1345-1362.e9. doi: 10.1016/j.ccell.2023.05.016. Epub 2023 Jun 22.
10
Research advances in endometriosis-related signaling pathways: A review.子宫内膜异位症相关信号通路的研究进展:综述。
Biomed Pharmacother. 2023 Aug;164:114909. doi: 10.1016/j.biopha.2023.114909. Epub 2023 May 19.